{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:04:24Z","timestamp":1765976664268},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T00:00:00Z","timestamp":1677283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>SAGIT is an instrument created for the clinical assessment of acromegaly. Our objective was to test the usefulness of this tool in assessing disease activity of acromegalic patients in a single centre of Poznan, Poland using a retrospective study. Medical records of patients with acromegaly hospitalised at the Department of Endocrinology, Metabolism and Internal Medicine of Poznan University of Medical Sciences in Poland between January 2015 and December 2020 were analysed. SAGIT scores were assessed according to each patient's clinical and biochemical data. The results show that SAGIT scores were higher in treatment-na\u00efve patients and the lowest in controlled patients. There were positive correlations between SAGIT scores and concentrations of calcium, phosphorus, HbA1C levels, and tumour invasiveness at the time of diagnosis. However, parameters such as age, vitamin D concentration, and time from diagnosis showed an inverse relationship with the SAGIT score. In ROC curve analysis, SAGIT scores of 5 or less discriminated controlled patients from uncontrolled (p\u2009&lt;\u20090.0001, sensitivity 76.7%, specificity 78.5%, AUC 0.867). Also, SAGIT higher than 6 indicated for treatment start or escalation (p\u2009&lt;\u20090.0001, sensitivity 80.88%, specificity 77.59%, AUC 0.866). Lack of signs and symptoms (S\u2009=\u20090) could not discriminate between controlled and uncontrolled disease, but predicted therapy maintenance (p\u2009&lt;\u20090.0004, sensitivity 59.5%, specificity 58.2%, AUC 0.604). In conclusion, The SAGIT instrument is easy to use even when completed in the retrospective medical record review. It can be useful for distinguishing clinical stages of acromegaly and in decision-making.<\/jats:p>","DOI":"10.1038\/s41598-023-29957-3","type":"journal-article","created":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T11:02:49Z","timestamp":1677322969000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The potential utility of the SAGIT instrument in the clinical assessment of patients with acromegaly, a large single-centre study"],"prefix":"10.1038","volume":"13","author":[{"given":"Nadia","family":"Sawicka-Gutaj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulina","family":"Zi\u00f3\u0142kowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Biczysko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abikasinee","family":"Erampamoorthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Ziemnicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Rucha\u0142a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,25]]},"reference":[{"key":"29957_CR1","doi-asserted-by":"crossref","unstructured":"Melmed, S. Acromegaly pathogenesis and treatment. J. Clin. Invest. 119(11), 3189\u20133202 (2009). https:\/\/www.mp.pl\/paim\/issue\/article\/16232.","DOI":"10.1172\/JCI39375"},{"key":"29957_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/540398","volume":"2012","author":"G Lugo","year":"2012","unstructured":"Lugo, G., Pena, L. & Cordido, F. Clinical manifestations and diagnosis of acromegaly. Int. J. Endocrinol. 2012, 1\u201310 (2012).","journal-title":"Int. J. Endocrinol."},{"issue":"1","key":"29957_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","volume":"20","author":"L Vilar","year":"2017","unstructured":"Vilar, L., Vilar, C. F., Lyra, R., Lyra, R. & Naves, L. A. Acromegaly: Clinical features at diagnosis. Pituitary 20(1), 22\u201332 (2017).","journal-title":"Pituitary"},{"issue":"3\u20134","key":"29957_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1159\/000095532","volume":"83","author":"SM Webb","year":"2006","unstructured":"Webb, S. M. Quality of life in acromegaly. Neuroendocrinology 83(3\u20134), 224\u2013229 (2006).","journal-title":"Neuroendocrinology"},{"key":"29957_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.2147\/PRBM.S183950","volume":"12","author":"E Solomon","year":"2019","unstructured":"Solomon, E. et al. Executive functioning and quality of life in acromegaly. Psychol. Res. Behav. Manag. 12, 39\u201344 (2019).","journal-title":"Psychol. Res. Behav. Manag."},{"key":"29957_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s11102-016-0725-2","volume":"19","author":"A Abreu","year":"2016","unstructured":"Abreu, A. et al. Challenges in the diagnosis and management of acromegaly: A focus on comorbidities. Pituitary 19, 448\u2013457 (2016).","journal-title":"Pituitary"},{"issue":"1","key":"29957_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000438903","volume":"103","author":"AS Powlson","year":"2016","unstructured":"Powlson, A. S. & Gurnell, M. Cardiovascular disease and sleep-disordered breathing in acromegaly. Neuroendocrinology 103(1), 75\u201385 (2016).","journal-title":"Neuroendocrinology"},{"issue":"2","key":"29957_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s11892-017-0838-7","volume":"17","author":"AM Hannon","year":"2017","unstructured":"Hannon, A. M., Thompson, C. J. & Sherlock, M. Diabetes in patients with acromegaly. Curr. Diab. Rep. 17(2), 8 (2017).","journal-title":"Curr. Diab. Rep."},{"issue":"1","key":"29957_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s11102-012-0383-y","volume":"16","author":"MCC dos Santos","year":"2013","unstructured":"dos Santos, M. C. C. et al. Thyroid cancer in patients with acromegaly: A case-control study. Pituitary 16(1), 109\u2013114 (2013).","journal-title":"Pituitary"},{"key":"29957_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fendo.2019.00390","volume":"2019","author":"D Dworakowska","year":"2019","unstructured":"Dworakowska, D. & Grossman, A. B. Colonic cancer and acromegaly. Front. Endocrinol. [Internet]. 2019, 10. https:\/\/doi.org\/10.3389\/fendo.2019.00390 (2019).","journal-title":"Front. Endocrinol. [Internet]."},{"issue":"3","key":"29957_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11154-019-09506-y","volume":"20","author":"F Gatto","year":"2019","unstructured":"Gatto, F. et al. Current perspectives on the impact of clinical disease and biochemical control on comorbidities and quality of life in acromegaly. Rev. Endocr. Metab. Disord. 20(3), 365\u2013381 (2019).","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"5","key":"29957_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.5603\/EP.a2016.0031","volume":"67","author":"C Wen-Ko","year":"2016","unstructured":"Wen-Ko, C. et al. The impact of diabetes mellitus on the survival of patients with acromegaly. Endokrynol. Pol. 67(5), 501\u2013506 (2016).","journal-title":"Endokrynol. Pol."},{"issue":"9","key":"29957_CR13","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","volume":"14","author":"S Melmed","year":"2018","unstructured":"Melmed, S. et al. A Consensus Statement on acromegaly therapeutic outcomes. Nat. Rev. Endocrinol. 14(9), 552\u2013561 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"29957_CR14","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.endinu.2018.01.008","volume":"65","author":"I Bernabeu","year":"2018","unstructured":"Bernabeu, I. et al. Criteria for diagnosis and postoperative control of acromegaly, and screening and management of its comorbidities: Expert consensus. Endocrinol. Diabetes Nutr. 65(5), 297\u2013305 (2018).","journal-title":"Endocrinol. Diabetes Nutr."},{"issue":"3","key":"29957_CR15","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1530\/EJE-19-0732","volume":"182","author":"TLC Wolters","year":"2020","unstructured":"Wolters, T. L. C. et al. The effect of treatment on quality of life in patients with acromegaly: A prospective study. Eur. J. Endocrinol. 182(3), 319\u2013331 (2020).","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"29957_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11102-015-0681-2","volume":"19","author":"A Giustina","year":"2016","unstructured":"Giustina, A. et al. SAGIT: Clinician-reported outcome instrument for managing acromegaly in clinical practice\u2013development and results from a pilot study. Pituitary 19(1), 39\u201349 (2016).","journal-title":"Pituitary"},{"issue":"5","key":"29957_CR17","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11102-019-00977-5","volume":"22","author":"A Giustina","year":"2019","unstructured":"Giustina, A. et al. Staging and managing patients with acromegaly in clinical practice: Baseline data from the SAGIT validation study. Pituitary 22(5), 476\u2013487 (2019).","journal-title":"Pituitary"},{"issue":"12","key":"29957_CR18","first-page":"3555","volume":"106","author":"A Giustina","year":"2021","unstructured":"Giustina, A. et al. International multicenter validation study of the SAGIT instrument in acromegaly. J. Clin. Endocrinol. Metab. 106(12), 3555\u20133568 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"29957_CR19","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1530\/EC-21-0035","volume":"10","author":"EV Varlamov","year":"2021","unstructured":"Varlamov, E. V. et al. Clinical features and complications of acromegaly at diagnosis are not all the same: Data from two large referral centers. Endocr. Connect. 10(7), 731\u2013741 (2021).","journal-title":"Endocr. Connect."},{"issue":"11","key":"29957_CR20","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","volume":"99","author":"L Katznelson","year":"2014","unstructured":"Katznelson, L. et al. Acromegaly: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99(11), 3933\u20133951 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"29957_CR21","doi-asserted-by":"crossref","unstructured":"Publication ethics of human studies in the light of the Declaration of Helsinki\u2014a mini-review. J. Med. Sci. [Internet] (accessed 15 Jul 2022); https:\/\/jms.ump.edu.pl\/index.php\/JMS\/article\/view\/700.","DOI":"10.20883\/medical.e700"},{"issue":"10","key":"29957_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fendo.2019.00509","volume":"30","author":"G Vila","year":"2019","unstructured":"Vila, G., J\u00f8rgensen, J. O. L., Luger, A. & Stalla, G. K. Insulin resistance in patients with acromegaly. Front. Endocrinol. 30(10), 509 (2019).","journal-title":"Front. Endocrinol."},{"issue":"9","key":"29957_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.3389\/fendo.2018.00358","volume":"6","author":"F Ferra\u00f9","year":"2018","unstructured":"Ferra\u00f9, F., Albani, A., Ciresi, A., Giordano, C. & Cannav\u00f2, S. Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment. Front. Endocrinol. 6(9), 358 (2018).","journal-title":"Front. Endocrinol."},{"key":"29957_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3389\/fendo.2022.816426","volume":"2022","author":"M Bolanowski","year":"2022","unstructured":"Bolanowski, M. et al. Acromegaly: Clinical care in Central and Eastern Europe, Israel, and Kazakhstan. Front. Endocrinol. [Internet]. 2022, 13. https:\/\/doi.org\/10.3389\/fendo.2022.816426 (2022).","journal-title":"Front. Endocrinol. [Internet]."},{"issue":"4","key":"29957_CR25","first-page":"459","volume":"94","author":"J Halse","year":"1980","unstructured":"Halse, J. & Haugen, H. N. Calcium and phosphate metabolism in acromegaly. Acta Endocrinol. (Copenh). 94(4), 459\u2013467 (1980).","journal-title":"Acta Endocrinol. (Copenh)."},{"key":"29957_CR26","first-page":"26","volume":"71","author":"T Xie","year":"2020","unstructured":"Xie, T. et al. Serum phosphate: Does it more closely reflect the true state of acromegaly?. J. Clin. Neurosci. Off. J. Neurosurg. Soc. Austral. 71, 26\u201331 (2020).","journal-title":"J. Clin. Neurosci. Off. J. Neurosurg. Soc. Austral."},{"issue":"7","key":"29957_CR27","doi-asserted-by":"publisher","first-page":"2416","DOI":"10.1210\/jc.2016-3693","volume":"102","author":"T Constantin","year":"2017","unstructured":"Constantin, T. et al. Calcium and bone turnover markers in acromegaly: A prospective, controlled study. J. Clin. Endocrinol. Metab. 102(7), 2416\u20132424 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"29957_CR28","doi-asserted-by":"publisher","first-page":"e86","DOI":"10.4158\/EP13228.CR","volume":"20","author":"P Manroa","year":"2014","unstructured":"Manroa, P., Kannan, S., Hatipoglu, B. & Licata, A. Hypercalcemia and acromegaly-clarifying the connections: A case report and review of the literature. Endocr. Pract. 20(5), e86-90 (2014).","journal-title":"Endocr. Pract."},{"issue":"S1","key":"29957_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11102-010-0286-8","volume":"15","author":"R Shah","year":"2012","unstructured":"Shah, R., Licata, A., Oyesiku, N. M. & Ioachimescu, A. G. Acromegaly as a cause of 1,25-dihydroxyvitamin D-dependent hypercalcemia: Case reports and review of the literature. Pituitary 15(S1), 17\u201322 (2012).","journal-title":"Pituitary"},{"issue":"1","key":"29957_CR30","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12902-021-00756-z","volume":"21","author":"S Shi","year":"2021","unstructured":"Shi, S., Zhang, L., Yu, Y., Wang, C. & Li, J. Acromegaly and non-parathyroid hormone-dependent hypercalcemia: A case report and literature review. BMC Endocr. Disord. 21(1), 90 (2021).","journal-title":"BMC Endocr. Disord."},{"key":"29957_CR31","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fendo.2015.00089\/abstract","volume":"2","author":"AJ Halupczok","year":"2015","unstructured":"Halupczok, A. J., Jawiarczyk-Przyby, A. & Bolanowski, M. Patients with active acromegaly are at high risk of 25(OH)D deficiency. Front. Endocrinol. [Internet]. 2, 6. https:\/\/doi.org\/10.3389\/fendo.2015.00089\/abstract (2015).","journal-title":"Front. Endocrinol. [Internet]."},{"issue":"6","key":"29957_CR32","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/BF03345496","volume":"25","author":"A Colao","year":"2002","unstructured":"Colao, A. et al. Gender- and age-related differences in the endocrine parameters of acromegaly. J. Endocrinol. Invest. 25(6), 532\u2013538 (2002).","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"29957_CR33","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1210\/jc.2017-01844","volume":"103","author":"SH Park","year":"2018","unstructured":"Park, S. H. et al. Age- and sex-specific differences as predictors of surgical remission among patients with acromegaly. J. Clin. Endocrinol. Metab. 103(3), 909\u2013916 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"29957_CR34","doi-asserted-by":"crossref","unstructured":"Bogus\u0142awska, A. et al. Gender and age differences among patients with acromegaly. Pol. Arch. Intern. Med. (2022; accessed 21 May 2022); https:\/\/www.mp.pl\/paim\/issue\/article\/16232.","DOI":"10.20452\/pamw.16232"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29957-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29957-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,25]],"date-time":"2023-02-25T11:08:46Z","timestamp":1677323326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-29957-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["29957"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-29957-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,25]]},"assertion":[{"value":"3 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3286"}}